Companies are realizing the value of. cost-effective option. an opinion regarding a business company performance.

Similar documents
Report on APEC-Funded Medical Device Delegation Visit Program to Australia, and Canada and the United States

Take a Course of Action.

FINAL STATUS DOCUMENT

Audit and Inspection

International Medical Device Regulatory Harmonization. Reality or Fantasy?

Global Workforce Trends. Quarterly Market Report September 2017

International trend on medical device regulatory convergence

International Trend on Medical Device Regulatory Convergence

Country Requirements for Employer Notification or Approval

Role and Vision of PMDA

Trends in the development of regulatory systems by the example of ICH countries

International Recruitment Solutions. Company profile >

Research on the Global Impact of the Ronald McDonald House Program

Background to CLP. Presentation Overview. Why Introduce GHS? Basic CLP requirements 8/30/2011

Implementing Economic Policy for Innovation and Entrepreneurship: The Mexican Case. Lorenza Martinez April, 2012

PMDA Update: Its current situation

Progress Report in 2016

Emerging Markets and Countries for Outsourcing Summary Digest

Fundamentals in Regulatory Affairs for Medical Technologies

Healthcare Practice. Healthcare PanelBook 2017

Best Private Bank Awards 2018

The Alliance 4 Universities. At the forefront of research, academic excellence, and technology & innovation

A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program

ECOPRENEUR 2012 Green entrepreneurship international program ULAANBAATAR MONGOLIA

ManpowerGroup Employment Outlook Survey Global

ManpowerGroup Employment Outlook Survey Global

Q Manpower. Employment Outlook Survey Global. A Manpower Research Report

PMDA EPOCH Toward 2020

SUMMARY REPORT OF THE 17 th ACCSQ MDPWG MEETING

Q Manpower. Employment Outlook Survey Global. A Manpower Research Report

GCP Inspection by PMDA

Introduction of AHWP. IMDRF Stakeholder Meeting 25 March 2015

International Trade. Virginia Economic Development Partnership. Presented By: Ellen Meinhart

Helping you capture new markets

E-Seminar. Teleworking Internet E-fficiency E-Seminar

Compensation. Benefits. Expatriation.

University of Wyoming End of Semester Fall 2013 Students by Country & Site

Turbocharging Mexico s Innovation Stephen Ezell VP, Global Innovation Policy ITIF. Mexico Innovation Week March 30, 2017

A new initiative to catalyze high-impact NAMAs and create a vibrant practitioner network on low-carbon development

2007 Daegu Initiative

Q Manpower. Employment Outlook Survey Global. A Manpower Research Report

Regional Alignment in Asia Pacific -

Food Safety Capacity Building: The role of public private partnerships

Clinical Research Professionals

Q Manpower. Employment Outlook Survey Global. A Manpower Research Report

RULES for the. EUROPEAN HEART RHYTHM ASSOCIATION (EHRA) (a Registered Branch of the ESC)

IRB review of international research. Pre-conference P1 FCPA 3 rd Party Due Diligence for Health Entities. Today

FDA s Clinical Trial Inspections in China Including FDA Overall Goals

IVDD revision changes to the European regulation of in-vitro diagnostic (IVD) Medical Devices. Med-Info. TÜV SÜD Product Service GmbH

Overview of ICH. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Open to the World: International Cooperation in Horizon 2020 and the Co-Funding Mechanisms UKRO Conference Glasgow, 1 July 2016

MSc REGULATORY AFFAIRS MEDICINES / MEDICAL DEVICES PROSPECTUS

COUNCIL DECISION 2014/913/CFSP

Information Note. Date: I-Note Number: Contact: Title. Executive Summary. Audience. Action. The international dimension of Erasmus+ 16/09/2014 IUIN22

ICH Regulators Forum. Dr Peter Arlett EU

Standards for improvement in health care: supervision, certification and accreditation in Europe

Global Location Trends: Asia-Pacific Facts & Figures

Development of Emergency Medicine in the Far East. Prof V. Anantharaman Department of Emergency Medicine Singapore General Hospital

Q4/13. Contents. Hong Kong Employment Outlook. Global Employment Outlook. About the Survey. About ManpowerGroup. Sector Comparisons

Consideration on Global Harmonization

ANVISA - Enhancing marketing authorization of drugs and medical devices in accordance to the international best practices

DELIVERING THE GLOBAL BUSINESS ELITE AUDIENCE

International Cooperation through Horizon IGLO Brussels, 25 February 2016

The Erasmus + Programme. Key activity 1 International Credit Mobility. What s new?

EUREKA Innovation across borders

Committee on the U.S. Commitment to Global Health

Fundamentals in Regulatory Affairs for Medical Technologies

Manpower Employment Outlook Survey Australia

Designation of Australian conformity assessment bodies for medical devices Implementation, Version 1.0, November 2016

FOREIGN DIRECT INVESTMENT

Andy Grove Scholarship for Intel Employees' Children Q&A

Manpower Employment Outlook Survey

ManpowerGroup Employment Outlook Survey New Zealand

Ghassan Karam Project Manager ICTRP - WHO, Geneva

Observers Takuya Noro MHLW X X X Hideto Yokoi PMDA Advisor X X X Adriana Gamboa INFARMED X X X

Manpower Employment Outlook Survey

Regulatory Control of Diagnostics in Tanzania. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority

Regional and sub-regional approaches to the Digital Economy: Lessons from Asia Pacific and Latin America

ManpowerGroup Employment Outlook Survey Hong Kong

Manpower Employment Outlook Survey India. A Manpower Research Report

4th International Medical Expo & Conference

Fulbright Scholar Research Opportunities

Opening markets and promoting good governance. Government Procurement Agreement

CQA Consultant of HVCC, Hilversum, the Netherlands. Coaching of auditors on various levels is an on-going activity.

International Opportunities

Miguel Pérez, Ph.D. Chairman Chamber of Chilean IT Companies. Asociación Chilena de Empresas de Tecnologías de Información A.G.

Regulatory Updates Health Sciences Authority Singapore

ManpowerGroup Employment Outlook Survey Global

Asian Open Access Meeting Report

Q Manpower. Employment Outlook Survey India. A Manpower Research Report

Overview of Joint Commission International

American Thoracic Society ATS GLOBAL ACTIVITIES REPORT 2015

IMDRF Project: List of international standards recognized by IMDRF management committee members

APEC LSIF Blood Supply Chain Initiative Overview

Welcome to Bell Reservationless Audio Conferencing. A guide to help you get started with your new Bell service

A Competitiveness Policy for the Medical Technology Industry: Six Policy Proposals to Sustain American Leadership

Medical Tourism: Global Context & The Economic Justification for Lithuania

How to Conduct Robust Root Cause Investigations for CAPA (Corrective and Preventive Action)

Boston MedTech Advisors

Q Manpower. Employment Outlook Survey Global. A Manpower Research Report

Transcription:

SPEAKER:- CHINMOY ROY WORLD COMPLIANCE SEMINARS WORLD COMPLIANCE SEMINARS BSEE, MSCS US FDA EXPERT DATA INTEGRITY & CSV. SPEAKER:- David R. Dills Global Regulatory Affairs & Compliance Consultant and President, NovaQual 1 Seminars 2 Onsite Training 3 Consulting 1 Consulting is providing expert We provide onsite Business Seminars Companies are realizing the value of and Employee Development Workshops bringing training on-site. it is a flexible, knowledge when a company needs Designed to improve employee & cost-effective option. an opinion regarding a business company performance. decision. 2 DAYS SEMINAR ON PRODUCT REGISTRATION AND NAVIGATING THE APPROVAL PROCESS WITH REGULATORY AUTHORITIES IN ASIA PACIFIC, EUROPE, MIDDLE EAST AND THE AMERICAS 12 RAPS CREDITS LOCATION : BOSTON, MA APRIL 25-26 Contact William Shaw Conference Manager 954-947-5670

COURSE SUMMARY Although China s medical regulatory bodies are becoming more harmonized with international standards, the Chinese registration process still poses significant difficulties for Western medical device and pharmaceutical firms. Learn how prepare the necessary documents and register your product with the Chinese regulatory authorities. As a special administrative region of China, Hong Kong has its own medical device regulations, separate from the mainland. While Hong Kong had little legislative control over the import of medical devices in the past, recent changes to Hong Kong s medical device registration system have led to stricter requirements. The Indian medical regulatory system has become more complicated in recent years. In the past, medical devices did not need to be approved at all, but that is not the case today. In India, there are about 30 device families that outline which specific medical devices need to be registered. Registration of medical devices in Japan is complicated, costly, and will generally take between 1-3 years depending on the device classification. In some cases, Japanese regulators require clinical trials in Japan to be conducted, and the costs of these trials can be very high. Product registration in Japan needs to be pursued carefully and only after determining that there is a strong market demand for your product. South Korea s medical regulatory system can be complicated for Western medical device manufacturers due to its increasingly strict requirements and Korea s unique business culture. Learn the process and determine the necessary documents and submitting your application to the Singaporean medical device regulatory authorities. The complexity level of Taiwan s medical device registration process is comparable to that of Japan s and China s registration processes, though somewhat simpler. In certain cases, U.S. or EU approvals can be substituted for local requirements. In addition, Taiwan s government has recently been overhauling the approval system to improve its efficiency. Before any medical device can be supplied in Australia, the device must be included in the Australian Register of Therapeutic Goods (ARTG) which is regulated by the Australian Therapeutic Goods Administration (TGA). Canada The Canadian Medical Device License (MDL) is required for companies selling Class II, III, or IV medical devices in Canada. The MDL is a product approval, while a MDEL is a permit for the company/distributor/importer itself. Canada's Medical Devices License (MDL) is comparable to the US FDA 510(k) process. United States One of the first steps towards selling a Class II medical device or IVD in the United States is to file a Premarket Notification with the FDA, also known as an FDA 510(k) submission. Technically, the FDA does not "approve" medical devices or IVDs for sale under the 510(k) process; the agency gives "clearance" for them to be sold in the U.S. We use the term "FDA approval" for simplicity. Premarket approval (PMA) is the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices. Mexico Mexico is the second largest medical device market in Latin America behind Brazil, and can prove to be a profitable target for medical device and IVD manufacturers. However, registering a device or IVD in Mexico can be challenging. COFEPRIS, the division of the Mexican Ministry of Health (Secretaría de Salud) is responsible for medical device and IVD oversight. South America Medical devices in Brazil are regulated by the Agência Nacional de Vigilância Sanitária (ANVISA). Brazil s base regulations and medical device classification schemes are similar to those found in the European MDD 93/42/EEC. Commercializing your medical device for sale in Peru requires registration with DIGEMID (Dirección General de Medicamentos, Insumos y Drogas), the country s medical device regulator. DIGEMID currently does not have a formal classification system in place, so a device s classification in its country of origin is usually accepted by Peruvian regulators. A four-tier classification system is currently under consideration by the Peruvian government. Europe In order to sell medical devices and IVDs in the European Union, you must first CE Mark your product. The CE Mark is not a quality mark, nor is it intended for consumers. CE marking indicates to EU regulators that your device meets all applicable requirements of the appropriate EU Directive, such as the Medical Devices Directive (MDD), In Vitro Diagnostic Device Directive (IVDD) or Active Implantable Medical Device Directive (AIMD), as they apply to your product. Israel Gaining access to the Israeli medical device market one of the largest in the Middle East requires registering your device with AMAR, the Israeli Ministry of Health s medical device regulation unit. Medical device registration in Israel is based having prior approval in one of the five founding Global Harmonization Task Force (GHTF) countries: Australia, Canada, Europe, Japan, or the United States. Manufacturers that have already obtained approval for their devices in those markets can leverage those registrations to satisfy most of Israel s medical device regulatory approval requirements. Turkey All medical devices imported into Turkey are required to have European CE marking. The classification of medical devices is the same used in the EU. Medical devices in Turkey are governed by the General Directorate of Pharmaceuticals and Pharmacy Department of Medical Device Services. The regulation covering medical devices is the Turkish Medical Devices Directive, which uses the framework of the EU Medical Devices Directive (MDD) 93/42/EEC. Here are some Take Key note of what you ll cover in two days of Workshop: As an added bonus, the seminar will address additional APAC and LATAM countries, including but not limited to, India, Malaysia, Indonesia, Philippines, Vietnam, Thailand, Columbia, Costa Rica, Ecuador, Panama, Peru and Venezuela. We will address these countries and more during our interactive and two-day discussions with your colleagues on the product registration and approval process and the subsequent challenges and recommended solutions. We address the structure of the regulatory agencies in the global markets and discuss local cultural nuances to help you be successful in working with the regulators. Speaker DAVID R. DILLS Global Regulatory Affairs & Compliance Consultant and President, NovaQual David R. Dills, Global Regulatory Affairs & Compliance Consultant, currently provides global regulatory affairs, compliance and quality consultative services for early-stage and established Class I/II/III medical device, including combination products, In Vitro Diagnostics, and biopharmaceutical manufacturers in multiple medical specialties and therapeutic areas on the global landscape, and has an accomplished record with more than 27 years of experience in the areas of Regulatory Affairs, Compliance and Quality Systems. He has been previously employed, with increasing responsibilities by medical device manufacturers and consultancies, including a globally recognized CRO and has worked directly with manufacturers engaged in compliance remediation activities and services involving consent decrees, CIA s, warning letters, 483 observations, and customer generated compliance events, and prepares for and conducts regulatory and compliance assessments. He leads and directs all activities for the product registration and approval process and working with the regulatory agencies in Asia Pacific (APAC), EU, Latin America (LATAM), Middle East, EMEA, including but not limited to FDA, European Medicines Agency, MHRH, ANVISA, MOH, PMDA, MOH, TFDA, MDCO, CFDA, TGA, Health Canada and others regarding multi-country product registrations and licensing. Mr. Dills manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations/commercial opportunities while developing strategies for governmental approval to introduce new products to market. He conducts communications with regulatory authorities and company representatives while executing an effective path to approval and helping with GxP compliance strategies in global markets.

LEARNING OBJECTIVES This seminar will provide an overview and in-depth snapshot of the product registration and approval process for Asia Pacific, Europe, Middle East, United States, Canada, Mexico and South America. Employees who will benefit include all levels of management and departmental representatives from key functional areas and those who desire a better understanding or a "refresh" overview of the registration and approval process in select countries, including: Regulatory Affairs Management Regulatory Affairs Specialist Auditors Compliance Officer Compliance Specialist Clinical Affairs Quality Assurance Management Marketing & Sales Distributors/Authorized Representatives Legal Counsel Engineering/Technical Services Operations/Manufacturing Consultants TRAINING TAILORED TO ACHIEVE THE FOLLOWING GOALS: Get assistance with medical device registration and medical device approval Learn how to access new markets and obtain medical device approval in all the countries listed Complete your registration in order to obtain medical device approval as efficiently as possible while realizing that some markets/countries will be more challenging Navigate the regulatory system, achieve product registration, and access the medical market In a group setting, review and discuss pain points, challenges and workable regulatory and compliance solutions TRAINING WILL BENEFIT: David R. Dills, is an independent Global Regulatory Affairs & Compliance Consultant and has an accomplished record with more than 26 years of experience in regulatory affairs, compliance and quality consultative services for early-stage/established Class I/II/III medical devices, IVD's, and bio/pharmaceutical manufacturers on the global landscape. CONFERENCE AGENDA DAY ONE (09:00 AM 06:00 PM) Topics: China, Japan, Australia, South Korea, Singapore, Hong Kong, Taiwan Which regulatory bodies in the Chinese government are responsible for medical device registration in China? In China, are medical devices required to be registered before What does the registration pathway look like for each What are the document requirements for registration for each In Hong Kong, are medical devices required to be registered before What are the advantages of registering for voluntary listing? What does the registration pathway look like for each What are the document requirements for In India, are medical devices required to be registered before What does the registration pathway look like for regulated medical Which regulatory bodies in the Japanese government are responsible for medical device registration in Japan? In Japan, are medical devices required to be registered before What are the different application categories for medical device What does the registration pathway look like for each What are the document requirements for notification for Class I medical What are the document requirements for registration for Class II medical What are the document requirements for registration for Class III and IV medical What are other requirements that are necessary for approval in addition to the device application? Which regulatory bodies in the Korean government are responsible for medical device registration in Korea? In Korea, are medical devices required to be registered before What does the registration pathway look like for each What are the document requirements for registration for each Which regulatory bodies in the Singaporean government are responsible for medical device registration in Singapore? Which regulatory organizations are considered independent reference agencies by the HSA? In Singapore, are medical devices required to be registered before they can be sold? What does the registration pathway look like for Class A medical What does the registration pathway look like for Class B-D medical What are the document requirements for registration for each regulatory classification? Assess the Australian TGA registration requirements for your device(s). Research the proper GMDN codes for your medical device(s) in Australia. Conduct a Technical File review to ensure completeness, review of clinical summary (a TGA requirement) and file documentation with the TGA. Determine the classification of your medical device according to Schedule 1 of the Canadian Medical Devices Regulations (CMDR) and knowing that devices fall into Class I, Class II, Class III or Class IV. Prepare 510(k) premarket notification and PMA (Premarket Approval) submissions for US FDA. Classify your device, choose the correct Premarket Submission and prepare the appropriate information for your Premarket Submission to the FDA. Determine the proper regulatory pathway for your devices andthe documentation required within the applicable registration route for Mexico. Determine classification of your medical device or IVD and determine a grouping strategy for your registration in Mexico and prepare and submit registration application documents to COFEPRIS. Determine the proper regulatory pathway for your devices and the documentation required within the applicable registration route with ANVISA in Brazil. Certain devices require INMETRO Certification in Brazil. For all classes, ANVISA reviews registration application and upon approval, ANVISA will publish registration number in the Diario Oficial da Uniao (DOU). Prepare a CE Marking Technical File or a Design Dossier (for a Class III device) that includes data demonstrating compliance with the applicable directives (MDD, IVDD, AIMD) in Europe. Medical device and IVD CE Marking Technical File or Design Dossier compilation and review. Verification of Essential Requirements and Europe. Implementation, modification and maintenance of a quality system (usually ISO 13485) that will meet European and other international requirements for Europe. Appoint an authorized representative in Israel to interact with AMAR on your behalf and manage your application process. Additional Requirements for Obtaining Medical Device Approval in Israel.

DAY TWO(09:00 AM 05:00 PM) What are the different regulatory classifications for medical Topics: US, Canada, Mexico, Europe, Israel, Brazil What does the registration pathway look like for each regulatory Which regulatory bodies in the Chinese government are classification? responsible for medical device registration in China? What are the document requirements for registration for each In China, are medical devices required to be registered before Is local testing (type testing/sample testing) required for What are the different regulatory classifications for medical What does the registration pathway look like for each Which regulatory bodies in the Singaporean government are What are the document requirements for registration for responsible for medical device registration in Singapore? each Which regulatory organizations are considered independent Is local testing (type testing/sample testing) required for reference agencies by the HSA? In Singapore, are medical devices required to be registered before Is approval in the Country of Origin required for What are the different regulatory classifications for medical In Hong Kong, are medical devices required to be registered before What does the registration pathway look like for Class A What are the advantages of registering for voluntary listing? medical What are the different regulatory classifications for medical What does the registration pathway look like for Class B-D medical What does the registration pathway look like for each What are the document requirements for registration for each What are the document requirements for Assess the Australian TGA registration requirements for your Is local testing (type testing/sample testing) required for device(s). Research the proper GMDN codes for your medical device(s) in Australia. Conduct a Technical File review to ensure completeness, In India, are medical devices required to be registered before review of clinical summary (a TGA requirement) and file documentation with the TGA. What are the different regulatory classifications for medical Determine the classification of your medical device according to Schedule 1 of the Canadian Medical Devices Regulations (CMDR) What does the registration pathway look like for regulated and knowing that devices fall into Class I, Class II, Class III or medical Class IV. Is local testing (type testing/sample testing) required for Prepare 510(k) premarket notification and PMA (Premarket Approval) submissions for US FDA. Classify your device, choose the correct Premarket Submission and prepare the appropriate information for your Premarket Which regulatory bodies in the Japanese government are Submission to the FDA. responsible for medical device registration in Japan? Determine the proper regulatory pathway for your devices and In Japan, are medical devices required to be registered before the documentation required within the applicable registration What are the different regulatory classifications for medical What are the different application categories for medical device What does the registration pathway look like for each What are the document requirements for notification for Class I medical What are the document requirements for registration for Class II medical What are the document requirements for registration for Class III and IV medical What are other requirements that are necessary for approval in addition to the device application? Is local testing (type testing/sample testing) required for Which regulatory bodies in the Korean government are responsible for medical device registration in Korea? In Korea, are medical devices required to be registered before route for Mexico. Determine classification of your medical device or IVD and determine a grouping strategy for your registration in Mexico and prepare and submit registration application documents to COFEPRIS. Determine the proper regulatory pathway for your devices and the documentation required within the applicable registration route with ANVISA in Brazil. Certain devices require INMETRO Certification in Brazil. For all classes, ANVISA reviews registration application and upon approval, ANVISA will publish registration number in the Diario Oficial da Uniao (DOU). Prepare a CE Marking Technical File or a Design Dossier (for a Class III device) that includes data demonstrating compliance with the applicable directives (MDD, IVDD, AIMD) in Europe. Medical device and IVD CE Marking Technical File or Design Dossier compilation and review. Verification of Essential Requirements and Europe. Implementation, modification and maintenance of a quality system (usually ISO 13485) that will meet European and other international requirements for Europe. Appoint an authorized representative in Israel to interact with AMAR on your behalf and manage your application process.

Some of our Testimonials David QU, senior Analytical Chemist Dalton Pharma Services I learned a lot from the instructor and trainee good. Nicola Mootoo, Senior Validation Engineer Shire Pharmaceuticals Seminar One Registration: Well placed, a lot of good information. Good interaction between participants.held at a good location." Evelyn Chang, Corporate manager Genzyme Well delivered seminars, right place, good contents. Mary Beird, Regulatory Compliance Manager Charles River laboratories International, Inc. The contents of the presentation and the discussion was very good" Our past Seminars at a Glance Corporate Package GET IN TOUCH 4029 Tomoka Drive Lake Worth, FL 33462 wshaw@worldcomplianceseminars.com www.worldcomplianceseminars.com Contact William Shaw Conference Manager 954-947-5670

REGISTRATION FORM NAME: ADDRESS: CITY, STATE, ZIP: PHONE NO: E-MAIL: NUMBER OF PEOPLE ATTENDING: NAME OF ATTENDEE: PAYMENT METHOD: VISA MC AMEX DISCOVER CHECK ENCLOSED CREDIT CARD NUMBER: EXP. DATE: CVV NO: COMMENTS:: DATE: PLACE: SIGNATURE: For more Details please Contact William Shaw, Conference Manager PH: 954-947-5670 Email: wshaw@worldcomplianceseminars.com